Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity

類似資料

• Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax
  著者:: Yamamoto, Brent J., 等
  出版事項: (2016)
• Animal‐to‐Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule
  著者:: Nagy, CF, 等
  出版事項: (2016)
• Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen
  著者:: Henning, Lisa N., 等
  出版事項: (2018)
• Evaluation of Intravenous Anthrax Immune Globulin for Treatment of Inhalation Anthrax
  著者:: Mytle, Nutan, 等
  出版事項: (2013)
• Pathology and Pathophysiology of Inhalational Anthrax in a Guinea Pig Model
  著者:: Savransky, Vladimir, 等
  出版事項: (2013)